BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25917077)

  • 1. Mesenchymal stem cells derived from low risk acute lymphoblastic leukemia patients promote NK cell antitumor activity.
    Entrena A; Varas A; Vázquez M; Melen GJ; Fernández-Sevilla LM; García-Castro J; Ramírez M; Zapata AG; Vicente Á
    Cancer Lett; 2015 Jul; 363(2):156-65. PubMed ID: 25917077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
    Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRTAM
    Ramírez-Ramírez D; Padilla-Castañeda S; Galán-Enríquez CS; Vadillo E; Prieto-Chávez JL; Jiménez-Hernández E; Vilchis-Ordóñez A; Sandoval A; Balandrán JC; Pérez-Tapia SM; Ortiz-Navarrete V; Pelayo R
    J Leukoc Biol; 2019 May; 105(5):999-1013. PubMed ID: 30791148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity.
    Copland IB; Qayed M; Garcia MA; Galipeau J; Waller EK
    Biol Blood Marrow Transplant; 2015 May; 21(5):934-40. PubMed ID: 25659882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cells derived from the bone marrow of acute lymphoblastic leukemia patients show altered BMP4 production: correlations with the course of disease.
    Vicente López Á; Vázquez García MN; Melen GJ; Entrena Martínez A; Cubillo Moreno I; García-Castro J; Orellana MR; González AG
    PLoS One; 2014; 9(1):e84496. PubMed ID: 24400095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses.
    Calkoen FG; Brinkman DM; Vervat C; van Ostaijen-Ten Dam MM; Ten Cate R; van Tol MJ; Ball LM
    Cytotherapy; 2013 Mar; 15(3):280-91. PubMed ID: 23312448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity.
    Pradier A; Passweg J; Villard J; Kindler V
    Cell Transplant; 2011; 20(5):681-91. PubMed ID: 21054933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and functional comparison of mesenchymal stem cells derived from the bone marrow of normal adults and patients with hematologic malignant diseases.
    Zhao ZG; Liang Y; Li K; Li WM; Li QB; Chen ZC; Zou P
    Stem Cells Dev; 2007 Aug; 16(4):637-48. PubMed ID: 17784837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological Features of Bone Marrow Mesenchymal Stromal Cells in Childhood Acute Lymphoblastic Leukemia.
    Genitsari S; Stiakaki E; Perdikogianni C; Martimianaki G; Pelagiadis I; Pesmatzoglou M; Kalmanti M; Dimitriou H
    Turk J Haematol; 2018 Mar; 35(1):19-26. PubMed ID: 28884706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia.
    Rouce RH; Shaim H; Sekine T; Weber G; Ballard B; Ku S; Barese C; Murali V; Wu MF; Liu H; Shpall EJ; Bollard CM; Rabin KR; Rezvani K
    Leukemia; 2016 Apr; 30(4):800-11. PubMed ID: 26621337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR7 guides migration of mesenchymal stem cell to secondary lymphoid organs: a novel approach to separate GvHD from GvL effect.
    Li H; Jiang Y; Jiang X; Guo X; Ning H; Li Y; Liao L; Yao H; Wang X; Liu Y; Zhang Y; Chen H; Mao N
    Stem Cells; 2014 Jul; 32(7):1890-903. PubMed ID: 24496849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cells adhere to bone marrow fibroblasts and inhibit adhesion of acute myeloid leukemia cells.
    Bendall LJ; Kortlepel K; Bradstock KF; Gottlieb DJ
    Leukemia; 1995 Jun; 9(6):999-1005. PubMed ID: 7596192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-associated alterations in marrow T cells in pediatric leukemia.
    Bailur JK; McCachren SS; Pendleton K; Vasquez JC; Lim HS; Duffy A; Doxie DB; Kaushal A; Foster C; DeRyckere D; Castellino S; Kemp ML; Qiu P; Dhodapkar MV; Dhodapkar KM
    JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32692727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
    Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T
    Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ability of multipotent mesenchymal stromal cells from the bone marrow of patients with leukemia to maintain normal hematopoietic progenitor cells.
    Sorokina T; Shipounova I; Bigildeev A; Petinati N; Drize N; Turkina A; Chelysheva E; Shukhov O; Kuzmina L; Parovichnikova E; Savchenko V
    Eur J Haematol; 2016 Sep; 97(3):245-52. PubMed ID: 26643284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological, functional and genetic characterization of bone marrow-derived mesenchymal stromal cells from pediatric patients affected by acute lymphoblastic leukemia.
    Conforti A; Biagini S; Del Bufalo F; Sirleto P; Angioni A; Starc N; Li Pira G; Moretta F; Proia A; Contoli B; Genovese S; Ciardi C; Avanzini MA; Rosti V; Lo-Coco F; Locatelli F; Bernardo ME
    PLoS One; 2013; 8(11):e76989. PubMed ID: 24244271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunomodulatory effects of mesenchymal stem cells derived from the bone marrow in acute leukemia patients].
    Zhao ZG; Sun L; Wang XF; Zhang YZ; Yu Y; Yang HL; Zou P
    Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):105-9. PubMed ID: 21575477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BM-MSCs display altered gene expression profiles in B-cell acute lymphoblastic leukemia niches and exert pro-proliferative effects via overexpression of IFI6.
    Pan C; Hu T; Liu P; Ma D; Cao S; Shang Q; Zhang L; Chen Q; Fang Q; Wang J
    J Transl Med; 2023 Sep; 21(1):593. PubMed ID: 37670388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice.
    Li Y; Qu YH; Wu YF; Wang XP; Wei J; Huang WG; Zhou DH; Fang J; Huang K; Huang SL
    Ann Hematol; 2011 Aug; 90(8):873-85. PubMed ID: 21234566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Immunomodulatory Effects of Human Bone Marrow-Derived Mesenchymal Stromal Cells on Natural Killer Cells.
    Hu CD; Kosaka Y; Marcus P; Rashedi I; Keating A
    Stem Cells Dev; 2019 Jul; 28(14):933-943. PubMed ID: 31122145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.